If you get a lower annual increase than expected, there may be ways to ask for more.
This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results